Arthroplasty

·MeSH: Agnosia

10 drugs in development·7 companies·1 clinical trial

Drug Pipeline by Phase

Approved(2)

Drug	Company
iovera°	Pacira BioSciences, Inc. (PCRX)
persona knee	Zimmer Biomet Holdings Inc. (ZBH)

Phase 3(1)

Drug	Company
EXPAREL	Valneva SE (VALN)

Phase 2(2)

Drug	Company
CTX611	CRISPR Therapeutics AG (CRSP)
xiaflex	Endo LP (NDOI)

Unknown(3)

Drug	Company
postoperative maxillary block	GH Research PLC (GHRS)
preoperative maxillary block	GH Research PLC (GHRS)
sham continuous adductor canal block - shacb nacl	GH Research PLC (GHRS)

Phase 4(2)

Drug	Company
Liposomal Bupivacaine	COLLEGIUM PHARMACEUTICAL, INC (COLL)
sham treatment	GH Research PLC (GHRS)

BioSniper tracks 10 drugs in development for Arthroplasty across 7 companies.

There are 1 clinical trial targeting Arthroplasty tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.